Order Article Reprints

Hecht M, Hahn D, Wolber P, Hautmann MG, Reichert D, Weniger S, Belka C, Bergmann T, Göhler T, Welslau M, et al. A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer. Cancers. 2021; 13(14):3413. https://doi.org/10.3390/cancers13143413

Hecht, Markus, Dennis Hahn, Philipp Wolber, Matthias G. Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, and et al. 2021. "A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer" Cancers 13, no. 14: 3413. https://doi.org/10.3390/cancers13143413

Hecht, M., Hahn, D., Wolber, P., Hautmann, M. G., Reichert, D., Weniger, S., Belka, C., Bergmann, T., Göhler, T., Welslau, M., Große-Thie, C., Guntinas-Lichius, O., von der Grün, J., Balermpas, P., Orlowski, K., Messinger, D., Stenzel, K. G., & Fietkau, R. (2021). A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer. Cancers, 13(14), 3413. https://doi.org/10.3390/cancers13143413